• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养药物在他汀不耐受患者中的作用。

The Role of Nutraceuticals in Statin Intolerant Patients.

机构信息

Department of Hypertension, Medical University of Lodz, and the Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.

Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

出版信息

J Am Coll Cardiol. 2018 Jul 3;72(1):96-118. doi: 10.1016/j.jacc.2018.04.040.

DOI:10.1016/j.jacc.2018.04.040
PMID:29957236
Abstract

Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.

摘要

他汀类药物是治疗心血管疾病患者最常用的药物。然而,由于他汀类药物相关的肌肉症状,在临床实践中坚持他汀类药物治疗具有挑战性。某些营养保健品,如红曲米、佛手、小檗碱、朝鲜蓟、可溶性纤维、植物甾醇和甾烷醇,单独或联合使用,以及与依折麦布联合使用,可被视为他汀类药物的替代或附加治疗方法,尽管关于它们在心血管疾病预防和治疗方面的长期安全性和有效性的证据仍然不足。这些营养保健品可能具有显著的降脂活性,并可能具有多种非降脂作用,包括改善内皮功能障碍和动脉僵硬,以及抗炎和抗氧化作用。本专家意见文件的目的是首次尝试通过使用营养保健品来管理他汀类药物不耐受,特别关注那些具有有效降低低密度脂蛋白胆固醇作用的营养保健品。

相似文献

1
The Role of Nutraceuticals in Statin Intolerant Patients.营养药物在他汀不耐受患者中的作用。
J Am Coll Cardiol. 2018 Jul 3;72(1):96-118. doi: 10.1016/j.jacc.2018.04.040.
2
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease.营养保健品(Armolipid Plus)与依折麦布及其联合用药对他汀类不耐受的冠心病血脂异常患者的有效性
Am J Cardiol. 2015 Dec 15;116(12):1798-801. doi: 10.1016/j.amjcard.2015.09.023. Epub 2015 Oct 3.
3
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia.营养保健品作为血脂异常联合治疗的重要组成部分。
Curr Pharm Des. 2017;23(17):2496-2503. doi: 10.2174/1381612823666170317145851.
4
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.临床实践中的降脂营养保健品:国际脂质专家小组的立场文件。
Nutr Rev. 2017 Sep 1;75(9):731-767. doi: 10.1093/nutrit/nux047.
5
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?营养保健品在血脂异常管理中的应用:何时、何地、何人适用?营养保健品能否帮助血脂水平非最佳的低危个体?
Curr Atheroscler Rep. 2021 Aug 4;23(10):57. doi: 10.1007/s11883-021-00955-y.
6
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.营养保健品在血脂异常高危患者降脂治疗中的作用。
Curr Atheroscler Rep. 2020 Sep 18;22(11):67. doi: 10.1007/s11883-020-00887-z.
7
Comparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis.营养保健品对血脂谱影响的比较:系统评价和网络荟萃分析方案。
BMJ Open. 2020 Aug 20;10(8):e032755. doi: 10.1136/bmjopen-2019-032755.
8
A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.一项关于营养保健品对成年人血脂谱影响的比较的网络荟萃分析。
Pharmacol Res. 2022 Sep;183:106402. doi: 10.1016/j.phrs.2022.106402. Epub 2022 Aug 18.
9
Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias.当前用于治疗血脂异常患者的药物和营养保健品。
Curr Pharm Des. 2019;25(1):85-95. doi: 10.2174/1381612825666190130101108.
10
Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance.血脂异常的当前治疗:前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂与他汀类药物不耐受
Swiss Med Wkly. 2016 Jul 11;146:w14333. doi: 10.4414/smw.2016.14333. eCollection 2016.

引用本文的文献

1
2024 update on postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.2024年上市后营养警戒安全性概况更新:一系列含红曲米的降血脂膳食补充剂
Arch Med Sci. 2024 Jun 16;21(3):729-737. doi: 10.5114/aoms/190111. eCollection 2025.
2
Effect of 14-Week Supplementation of Highly Purified Policosanol (Raydel) and a Sugar Cane Extract Powder (SCEP) on Dyslipidemia and Oxidative Variables in Hyperlipidemic Zebrafish: Insight into Liver, Kidney, and Brain Health.14周补充高纯度聚癸烯醇(Raydel)和甘蔗提取物粉末(SCEP)对高脂血症斑马鱼血脂异常和氧化指标的影响:对肝脏、肾脏和脑健康的见解
Curr Issues Mol Biol. 2025 May 13;47(5):354. doi: 10.3390/cimb47050354.
3
Global scientific trends in hypercholesterolemia research from 2003 to 2023: a data-driven bibliometric and visual analysis.
2003年至2023年全球高胆固醇血症研究的科学趋势:基于数据的文献计量学与可视化分析
Front Cardiovasc Med. 2025 Jun 11;12:1524697. doi: 10.3389/fcvm.2025.1524697. eCollection 2025.
4
Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects.揭示佛手柑的功效:超越降脂作用
Nutrients. 2025 May 30;17(11):1871. doi: 10.3390/nu17111871.
5
Evaluation of NaTto Red Yeast Rice on Regulating Blood Lipid (ENTRY) Study: A Multicenter, Double-Placebo, Double-Blinded, Randomized Controlled Trial in Chinese Adults.纳豆红曲调节血脂(ENTRY)研究评估:一项针对中国成年人的多中心、双安慰剂、双盲、随机对照试验。
Chronic Dis Transl Med. 2025 Apr 24;11(2):122-129. doi: 10.1002/cdt3.70005. eCollection 2025 Jun.
6
Exploring the Cardiovascular Potential of Artichoke-A Comprehensive Review.探索洋蓟的心血管潜力——综合综述
Biology (Basel). 2025 Apr 10;14(4):397. doi: 10.3390/biology14040397.
7
Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia.一种营养保健品组合对中重度高胆固醇血症儿童血脂谱的有益作用。
Biomolecules. 2024 Dec 16;14(12):1608. doi: 10.3390/biom14121608.
8
Extract, a Natural Approach for Cholesterol and Lipid Metabolism Management: A Randomized, Double-Blind Placebo-Controlled Clinical Trial.提取物,一种管理胆固醇和脂质代谢的天然方法:一项随机、双盲、安慰剂对照临床试验。
Foods. 2024 Nov 30;13(23):3883. doi: 10.3390/foods13233883.
9
Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review.治疗高胆固醇血症的膳食补充剂的疗效、副作用、依从性、可负担性和采购:叙述性综述。
J Health Popul Nutr. 2024 Nov 19;43(1):189. doi: 10.1186/s41043-024-00679-0.
10
Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis.依洛尤单抗和阿利西尤单抗作为 PCSK9 抑制剂在家族性高胆固醇血症儿科患者中的疗效和安全性:系统评价和荟萃分析。
Medicina (Kaunas). 2024 Oct 8;60(10):1646. doi: 10.3390/medicina60101646.